Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1988 1
1989 1
1992 1
1993 2
1994 1
1995 1
1996 6
1997 3
1998 2
1999 5
2000 2
2001 10
2002 11
2003 13
2004 10
2005 19
2006 7
2007 8
2008 8
2009 6
2010 7
2011 3
2012 6
2013 6
2014 5
2015 2
2016 6
2017 4
2018 3
2020 1
2021 4
2022 3
2023 3
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

158 results

Results by year

Filters applied: . Clear all
Page 1
Risk factors for CAR-T cell manufacturing failure among DLBCL patients: A nationwide survey in Japan.
Jo T, Yoshihara S, Okuyama Y, Fujii K, Henzan T, Kahata K, Yamazaki R, Takeda W, Umezawa Y, Fukushima K, Ashida T, Yamada-Fujiwara M, Hanajiri R, Yonetani N, Tada Y, Shimura Y, Nishikii H, Shiba N, Mimura N, Ando J, Sato T, Nakashima Y, Ikemoto J, Iwaki K, Fujiwara SI, Ri M, Nagamura-Inoue T, Tanosaki R, Arai Y. Jo T, et al. Among authors: tanosaki r. Br J Haematol. 2023 Jul;202(2):256-266. doi: 10.1111/bjh.18831. Epub 2023 Apr 25. Br J Haematol. 2023. PMID: 37096915 Free article.
Tumor immunity against adult T-cell leukemia.
Kannagi M, Harashima N, Kurihara K, Ohashi T, Utsunomiya A, Tanosaki R, Masuda M, Tomonaga M, Okamura J. Kannagi M, et al. Among authors: tanosaki r. Cancer Sci. 2005 May;96(5):249-55. doi: 10.1111/j.1349-7006.2005.00050.x. Cancer Sci. 2005. PMID: 15904464 Free PMC article. Review.
Adoptive cell therapy using tumor-infiltrating lymphocytes for melanoma refractory to immune-checkpoint inhibitors.
Hirai I, Funakoshi T, Kamijuku H, Fukuda K, Mori M, Sakurai M, Koda Y, Kato J, Mori T, Watanabe N, Noji S, Yaguchi T, Iwata T, Ohta S, Fujita T, Tanosaki R, Handa M, Okamoto S, Amagai M, Kawakami Y. Hirai I, et al. Among authors: tanosaki r. Cancer Sci. 2021 Aug;112(8):3163-3172. doi: 10.1111/cas.15009. Epub 2021 Jun 30. Cancer Sci. 2021. PMID: 34101300 Free PMC article. Clinical Trial.
Adult T-cell leukemia: future prophylaxis and immunotherapy.
Kannagi M, Harashima N, Kurihara K, Utsunomiya A, Tanosaki R, Masuda M. Kannagi M, et al. Among authors: tanosaki r. Expert Rev Anticancer Ther. 2004 Jun;4(3):369-76. doi: 10.1586/14737140.4.3.369. Expert Rev Anticancer Ther. 2004. PMID: 15161436 Review.
Progress in cell therapy in Japan 1999.
Takaue Y, Tanosaki R. Takaue Y, et al. Among authors: tanosaki r. Jpn J Clin Oncol. 1999 Mar;29(3):117-8. doi: 10.1093/jjco/29.3.117. Jpn J Clin Oncol. 1999. PMID: 10225692 No abstract available.
Adverse Events Associated With Infusion of Hematopoietic Stem Cell Products: A Prospective and Multicenter Surveillance Study.
Ikeda K, Ohto H, Okuyama Y, Yamada-Fujiwara M, Kanamori H, Fujiwara SI, Muroi K, Mori T, Kasama K, Iseki T, Nagamura-Inoue T, Fujii N, Ashida T, Kameda K, Kanda J, Hirose A, Takahashi T, Nagai K, Minakawa K, Tanosaki R. Ikeda K, et al. Among authors: tanosaki r. Transfus Med Rev. 2018 Jun 1:S0887-7963(18)30023-3. doi: 10.1016/j.tmrv.2018.05.005. Online ahead of print. Transfus Med Rev. 2018. PMID: 29891441 Free article. Review.
Comparison of cryoprotectants in hematopoietic cell infusion-related adverse events.
Ikeda K, Minakawa K, Yamahara K, Yamada-Fujiwara M, Okuyama Y, Fujiwara SI, Yamazaki R, Kanamori H, Iseki T, Nagamura-Inoue T, Kameda K, Nagai K, Fujii N, Ashida T, Hirose A, Takahashi T, Ohto H, Ueda K, Tanosaki R. Ikeda K, et al. Among authors: tanosaki r. Transfusion. 2022 Jun;62(6):1280-1288. doi: 10.1111/trf.16877. Epub 2022 Apr 9. Transfusion. 2022. PMID: 35396716
Immunogenicity of three versus four doses of 13-valent pneumococcal conjugate vaccine followed by 23-valent pneumococcal polysaccharide vaccine in allogeneic haematopoietic stem cell transplantation recipients: a multicentre, randomized controlled trial.
Okinaka K, Akeda Y, Inamoto Y, Fuji S, Ito A, Tanaka T, Kurosawa S, Kim SW, Tanosaki R, Yamashita T, Ohwada C, Kurata K, Mori T, Onozawa M, Takano K, Yokoyama H, Koh K, Nagafuji K, Nakayama K, Sakura T, Takahashi T, Oishi K, Fukuda T. Okinaka K, et al. Among authors: tanosaki r. Clin Microbiol Infect. 2023 Apr;29(4):482-489. doi: 10.1016/j.cmi.2022.12.007. Epub 2022 Dec 8. Clin Microbiol Infect. 2023. PMID: 36503114 Free article. Clinical Trial.
158 results